The clinical evidence for the harmful effect of cortisone on patients infected with tubercle bacilli (American Trudeau Society, 1952; Fred et al., 1951; Traut and Ellman, 1952) has been supported by a series of laboratory studies on mice (Hart and Ress, 1950) , rats (Cummings et al., 1952; Michael et al., 1950) , guinea pigs (Spain and Molomut, 1950) , and rabbits (Lurie et al., 1951). In the preceding study, it was shown that streptomycin could compensate for the deleterious effect of small but not large doses of cortisone.
Received for publication August 24, 1953 The clinical evidence for the harmful effect of cortisone on patients infected with tubercle bacilli (American Trudeau Society, 1952; Fred et al., 1951; Traut and Ellman, 1952) has been supported by a series of laboratory studies on mice (Hart and Ress, 1950) , rats (Cummings et al., 1952; Michael et al., 1950) , guinea pigs (Spain and Molomut, 1950) , and rabbits (Lurie et al., 1951) . In the preceding study, it was shown that streptomycin could compensate for the deleterious effect of small but not large doses of cortisone.
In this study corticotropin (ACTH) was administered to both primarily infected rabbits and rabbits previously sensitized. In contrast to the results with cortisone, corticotropin produced no deleterious effects on the animals when doses of 4 times the usual human therapeutic doses were employed. However, there was evidence of damage to the animals' resistance when doses 8 times the usual human dose were employed. Streptomycin prevented the harmful effect of the large doses of corticotropin.
Since one of the purposes of this work was to compare the effects of corticotropin and cortisone on the tuberculous process, it was necessary to find some way of comparing the dosages of these two hormones to determine if they were physiologically of the same magnitude. Use was made of the lymphocyte depressing ability of corticotropin and cortisone White, 1944, 1945) to accomplish this.
MATERIALS AND METHODS
Seventy-five white rabbits of mixed sexes weighing approximately two kg were used in this experiment. All rabbits were etherized, their tracheae were exposed, and 0.25 ml of homogenate 1 This investigation was supported in part by research grant G3807 from the National Institutes of Health, Public Health Service.
2 Frederick M. Hanes Research Fellow. containing 5 mg of Mycobacteriumn tuberculosis var bovis, Ravenel strain, was injected into the tracheae. The rabbits were held in such a manner that the homogenate drained into the right upper lobe of the lung. They were divided into 10 groups and used in the following experiments.
Experiment A. These rabbits were normal, unsensitized rabbits at the beginning of the experiment.
Group 1: Four rabbits were used as a control group and were not treated in any way. One died at 13 days and one at 16 days. Another was killed at one month, and the last one was killed at 3 months, the termination of the experiment.
Group II: Five rabbits were treated with 60 mg streptomycin sulfate in sterile saline injected intramuscularly once a day. At 30 days this dose was cut in half and continued until the end of the experiment. One rabbit was killed at one month and the remainder after 3 months.
Group III: Seven rabbits were treated with 2.5 units porcine corticotropin (ACTH, Armour) intramuscularly every 6 hours for a total of 10 units per day. At the end of 10 days this dose was reduced to 1.25 units every 6 hours, at the end of 20 days to 1.25 units every 12 hours, and at the end of 30 days it was discontinued. One rabbit was killed at one month, one died a week before the end of the experiment, and the remainder were killed after 3 months.
Group IV: Seven rabbits were treated with corticotropin and streptomycin using exactly the same procedur e for dose reduction of corticotropin as in group III. Streptomycin was administered as in group II. One rabbit was killed at one month and the remainder at 3 months. Experiment B. These rabbits were sensitized and partially immunized by the subcutaneous injection of 0. Group VI: Seven rabbits were treated with corticotropin and streptomycin using the same procedure for dose reduction of corticotropin as in group V which began with 5 units. Streptomycin was administered as in group II. One rabbit was killed at 7 weeks, and the remainder were killed at 11 weeks.
The methods of killing the animals and studying the disease produced in them were exactly the same as in the preceding study with the cortisone treated animals. All the lungs were studied grossly and micioscopically and were evaluated by the same numerical grading system as described before. Two of them had cavities with pus and adhesions; the rest had moderate disease. In general the disease was much less extensive than in the control group. Microscopically, the disease was of a spreading type with poor delimitation. A few tubercle bacilli were seen in every rabbit.
Group III: There were 7 rabbits in the corticotropin group, one of which died spontaneously.
Pleural adhesions, large cavities, extension to all lobes, involvement of hilar and tracheal nodes, and enlargement of the right lobes to 2 to 3 times normal size characterized the disease in these animals. AIicroscopically, there was extensive cavitation, which was defined rather well by epithelioid and fibroblastic proliferation, that was better than that seen in any other group.
Many tubercle bacilli were seen.
Group IV: There were 7 rabbits in the corticotropin-streptomycin group, none of which died spontaneously. The disease was much less than that of the controls and was about equal to that in the rabbits receiving streptomycin alone. There were few adhesions, little extension throughout the lung, few cavities, and no enlargement of lobes. figure 2 ). This generality was observed throughout all the groups in the experiment with no difference being made whether the animals were controls or whether they were receiving streptomycin, corticotropin, or a combination of both. This was found to be true also in the preceding study with cortisone.
The nonsensitized rabbits showed a much greater tendency than sensitized ones to cavity formation and extension to many lobes of the lung. Spread to the paratracheal nodes was much more common. Microscopic examination of the lesions of the nonsensitive animals revealed distinctly less fibroblastic proliferation surrounding areas of active disease, and the disease process, especially in the untreated controls, appeared to be more spreading in type than in the sensitized animals. Further, all of the unsensitized animals showed markedly increased numbers of 0-No disase; 1-few tubercles less than 1 mm; 2-moderate number tubercles less than 1 mm; 3-necrosis, few tubercles less than 2 mm; 4-necrosis, many tubercles less than 2 mm; 5-areas of necrosis, confluent disease; 6-much of lobe occupied with necrotic disease; 7-lobe filled with disease. Ratings for the individual 5 lobes were added together for the total rating of each rabbit.
tubercle bacilli in comparison with the sensitized rabbits. From these facts, it is evident that the sensitized state previous to tuberculous infection is an advantageous one, and with its presence the animal possesses a markedly increased resistance to tuberculosis.
In the following discussion of how streptomycin and corticotropin affect the tuberculous process, the same remarks in general will apply both to sensitized and nonsensitized animals, the only important difference being that the nonsensitized animals have an all-round increased severity. The degrees of severity of disease in the control, streptomycin, corticotropin, and streptomycincorticotropin groups hold the same relative position to one another in both sensitivity states. This can be seen from figure 2.
As many investigators have shown already, the effect of streptomycin is a beneficial one. In the sensitized streptomycin animals, nearly half of them had healed their disease and exhibited essentially normal lungs while the others were in a stage of healing with scar formation and little necrosis. In the nonsensitized rabbits, streptomycin did not produce as good results as were seen in the sensitive rabbits, and the disease approximately equalled in severity that seen in On the other hand, cortisone in both large (20 mg) and small (2 mg) doses seems to affect the host's reaction so that the disease becomes greater, and while streptomycin is able to neutralize the effect of small amounts of cortisone to produce almost complete healing, the larger dose of cortisone allows extensive disease equal to that in the controls to develop even when streptomycin is given at the same time.
We feel that these observations warrant classification of the therapeutic plans into groups as follows. To avoid confusion, only the sensitized animals are presented in this listing.
(1) Disease equal to the control group in severity: a. cortisone in large dose (20 mg) with streptomycin (60 mg); b. corticotropin in sma11 dose (10 units).
( 2) Two questions now remain to be settled. How do these doses of the two hormones compare with human doses, and how do they compare in units of physiological activity with one another? The latter question must certainly be settled in order to rule out the possibility that relatively larger physiological doses of cortisone were given and that this is the cause of the differences in results of the two hormones.
In those rabbits receiving 1 mg per kilo of cortisone, the dose was somewhat smaller than the usual human doses of 100 to 200 mg. In those rabbits receiving 10 mg per kilo of cortisone, the dose was 3 to 6 times in excess of human doses. Corticotropin doses, on the other hand, were at all times far in excess of human therapeutic levels being 4 to 20 times the 40 to 100 units human dose. It is significant in view of these facts to note that cortisone exerted its deleterious effect both at and above the human levels, whereas corticotropin could be administered in (Reinmuth and Smith, 1951 It is worth noting that all doses of corticotropin and cortisone that were used in the experiments were markedly higher than the smallest amounts that had a measurable effect on the lymphocytes, the corticotropin doses being around 33 to 66 times this smallest amount and the cortisone doses 8 to 80 times.
Seventy-five white rabbits were used in this experiment. Fifty-two were sensitized and partially immunized by the subcutaneous injection of the relatively avirulent R1v strain of Mycobacterium tuberculosis, and the others were not sensitized in any way. All of the rabbits were injected later intratracheally with 5 mg of the Ravenel strain of bovine tubercle bacillus. They were treated with streptomycin, corticotropin, and a combination of the two.
In general all groups of nonsensitized rabbits including controls showed much more extensive disease than the corresponding groups of sensitized animals.
Corticotropin in a 10 unit per day dose did not exert any damaging influence on the course of untreated tuberculosis, and it did not interfere with the beneficial healing effect of streptomycin. In a 20 unit per day dose, it caused disease slightly to moderately worse than that found in controls. However, this dose did not interfere with the healing effect of streptomycin.
These results are contrasted with those in the preceding study in which it was seen that cortisone in both large (20 mg per day) and small (2 mg per day) doses affected the host's reaction so that the disease became worse than that of controls.
In order to see that the dosage level of the two hormones was not causing this difference, use of the lymphocyte depresing ability of the hormones was made to determine the relative physiological amounts of each that were being administered to the rabbits. It was found that relatively more corticotropin than cortisone was being given, so dosage cannot account for the poor results obtained with cortisone.
Cortisone exerted its deleterious effect both at and above human dosage levels, whereas corticotropin could be administered in excess of human dose levels without harmful effect and was deleterious only at levels 20 times the human dose.
